Free tool
FAERS Monitor: Magnesium Sulfate In Dextrose 5% In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020488 or its brand name (Magnesium Sulfate In Dextrose 5% In Plastic Container, Magnesium Sulfate). Reports on generic versions are filed under their own applications.
Reports
102
Serious
89
87% of reports
Hospitalization
32
Death reported
18
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective22
- exposure during pregnancy11
- off label use11
- hypermagnesaemia8
- maternal exposure during pregnancy8
- acute kidney injury7
- pulmonary oedema7
- hyperglycaemia6
- bile duct obstruction5
- blood bilirubin increased5
- diarrhoea5
- pyrexia5
- toxicity to various agents5
- hyperkalaemia4
- acute respiratory failure3
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 7 |
| 2017 | 4 |
| 2018 | 9 |
| 2019 | 8 |
| 2020 | 1 |
| 2021 | 16 |
| 2022 | 24 |
| 2023 | 17 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 5 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,057 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| hypermagnesaemiaSignal | 8 | 2560.2 | 1310.5 | 17,766 |
| bile duct obstructionSignal | 5 | 544.9 | 231.5 | 2,192 |
| blood bilirubin increasedSignal | 5 | 38.2 | 16.2 | 146 |
| exposure during pregnancySignal | 11 | 36.5 | 20.9 | 346 |
| hyperglycaemiaSignal | 6 | 34.0 | 15.6 | 161 |
| pulmonary oedemaSignal | 7 | 32.2 | 15.8 | 182 |
| acute respiratory failureSignal | 3 | 32.2 | 10.5 | 62 |
| hyperkalaemiaSignal | 4 | 23.5 | 9.0 | 65 |
| maternal exposure during pregnancySignal | 8 | 18.5 | 9.5 | 116 |
| acute kidney injurySignal | 7 | 9.4 | 4.6 | 45 |
| toxicity to various agentsSignal | 5 | 6.1 | 2.6 | 17 |
| drug ineffectiveSignal | 22 | 3.4 | 2.4 | 38 |
| pyrexiaSignal | 5 | 3.0 | 1.3 | 5 |
| off label useSignal | 11 | 2.6 | 1.5 | 10 |
| diarrhoea | 5 | 1.6 | 0.7 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.